The long-term objectives are to understand the early signal transduction and second messenger systems which control neutrophil responses (e.g., secretion, chemotaxis), with particular emphasis on protein kinase C activating/inhibiting factors and lipid-derived mediators including diacylglycerol (DAG), sphingosine, and alkyl, acylglycerol (EAG). Information and new methodologies deriving from these studies are expected to be widely applicable to a variety of systems, including oncogene-related pathways wherein protein kinase C and associated pathways are perturbed and may participate in cancer development. These studies will also provide important fundamental information relating to altered neutrophil function in AIDS and Localized Juvenile Periodontitis, and pathological roles for neutrophils in such conditions as Reperfusion Injury, as, for example, following a myocardial infarction. Studies investigating neutrophil priming using Granulocyte/Monocyte Colony Stimulating Factor (GM-CSF) are expected to be directly relevant to understanding how this factor corrects the defect in neutrophils from AIDS patients. Studies will focus on the regulation of lipid metabolic pathways which participate in the generation of bioactive lipid mediators, their perturbation in LJP, and their modulation by priming factors and cyclic AMP. Techniques which will be used include analysis of diglyceride molecular species (chemical derivatization and HPLC), analysis of phospholipid headgroup release (mass and radiochemical analyses), protein phosphorylation (autoradiography), lipid mediator analysis (radiochemical methods) and a variety of other biochemical analytical methods.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA046508-06
Application #
3189779
Study Section
Biochemistry Study Section (BIO)
Project Start
1987-06-01
Project End
1995-05-31
Budget Start
1992-06-01
Budget End
1993-05-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Kuai, J; Boman, A L; Arnold, R S et al. (2000) Effects of activated ADP-ribosylation factors on Golgi morphology require neither activation of phospholipase D1 nor recruitment of coatomer. J Biol Chem 275:4022-32
Xu, X X; Yi, T; Tang, B et al. (1998) Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2. Oncogene 16:1561-9
Baek, S H; Kwak, J Y; Lee, S H et al. (1997) Lipase activities of p37, the major envelope protein of vaccinia virus. J Biol Chem 272:32042-9
Seo, J K; Choi, S Y; Kim, Y et al. (1997) A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol 158:1895-901
Kim, J H; Suh, Y J; Lee, T G et al. (1996) Inhibition of phospholipase D by a protein factor from bovine brain cytosol. Partial purification and characterization of the inhibition mechanism. J Biol Chem 271:25213-9
Olson, S C; Lambeth, J D (1996) Biochemistry and cell biology of phospholipase D in human neutrophils. Chem Phys Lipids 80:3-19
Lopez, I; Burns, D J; Lambeth, J D (1995) Regulation of phospholipase D by protein kinase C in human neutrophils. Conventional isoforms of protein kinase C phosphorylate a phospholipase D-related component in the plasma membrane. J Biol Chem 270:19465-72
Kwak, J Y; Lopez, I; Uhlinger, D J et al. (1995) RhoA and a cytosolic 50-kDa factor reconstitute GTP gamma S-dependent phospholipase D activity in human neutrophil subcellular fractions. J Biol Chem 270:27093-8
Lambeth, J D; Kwak, J Y; Bowman, E P et al. (1995) ADP-ribosylation factor functions synergistically with a 50-kDa cytosolic factor in cell-free activation of human neutrophil phospholipase D. J Biol Chem 270:2431-4
Bowman, E P; Uhlinger, D J; Lambeth, J D (1995) Neutrophil phospholipase D: inhibition by Rho-GDP dissociation inhibitor and stimulation by small GTPase GDP dissociation stimulator. Methods Enzymol 256:246-56

Showing the most recent 10 out of 41 publications